IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 227 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,443,796 | -26.7% | 1,448,435 | -2.1% | 0.09% | -27.6% |
Q1 2024 | $12,890,486 | -50.4% | 1,479,964 | -34.8% | 0.12% | -52.1% |
Q4 2023 | $25,969,281 | +22.0% | 2,270,042 | +2.7% | 0.26% | +8.9% |
Q3 2023 | $21,291,785 | +504.1% | 2,210,985 | +566.8% | 0.24% | +505.1% |
Q2 2023 | $3,524,738 | -22.3% | 331,584 | -23.1% | 0.04% | -38.1% |
Q1 2023 | $4,536,929 | +50.3% | 431,267 | +77.1% | 0.06% | +43.2% |
Q4 2022 | $3,017,919 | +0.5% | 243,577 | -16.0% | 0.04% | -4.3% |
Q3 2022 | $3,004,000 | -87.7% | 290,002 | -86.3% | 0.05% | -86.5% |
Q2 2022 | $24,344,000 | +3.1% | 2,109,530 | +12.4% | 0.34% | +22.1% |
Q1 2022 | $23,609,000 | +17.3% | 1,876,727 | +9.1% | 0.28% | +26.7% |
Q4 2021 | $20,135,000 | +0.3% | 1,720,956 | +11.9% | 0.22% | -2.6% |
Q3 2021 | $20,077,000 | +0.9% | 1,537,262 | -0.7% | 0.23% | +10.7% |
Q2 2021 | $19,900,000 | +308.7% | 1,547,452 | +255.3% | 0.20% | +327.1% |
Q1 2021 | $4,869,000 | +1.3% | 435,529 | +3.1% | 0.05% | 0.0% |
Q4 2020 | $4,806,000 | +1075.1% | 422,348 | +828.4% | 0.05% | +1100.0% |
Q3 2020 | $409,000 | – | 45,491 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 5,885,583 | $88,225,000 | 9.93% |
Sarissa Capital Management LP | 1,650,000 | $24,733,000 | 6.33% |
SENZAR ASSET MANAGEMENT, LLC | 1,448,800 | $21,718,000 | 5.54% |
SECTOR GAMMA AS | 1,188,553 | $17,816,000 | 3.00% |
Broderick Brian C | 487,065 | $7,301,000 | 2.66% |
Virtus ETF Advisers LLC | 62,500 | $937,000 | 1.18% |
Brown Capital Management | 6,263,825 | $93,895,000 | 1.14% |
Penn Capital Management Company, LLC | 857,747 | $12,955,000 | 0.90% |
Orbimed Advisors | 4,525,200 | $67,833,000 | 0.86% |
Capital Impact Advisors, LLC | 93,341 | $1,399,000 | 0.60% |